Global Sustained Release Ocular Drug Delivery Systems Market Insights and Forecast to 2028

Global Sustained Release Ocular Drug Delivery Systems Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Sustained Release Ocular Drug Delivery Systems Product Introduction
1.2 Market by Type
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Market by Application
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Estimates and Forecasts 2017-2028
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Estimates and Forecasts 2017-2028
2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Sustained Release Ocular Drug Delivery Systems Sales by Region
2.4.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022)
2.4.2 Global Sales Sustained Release Ocular Drug Delivery Systems by Region (2023-2028)
2.5 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region
2.5.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022)
2.5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers
3.1.1 Global Top Sustained Release Ocular Drug Delivery Systems Manufacturers by Sales (2017-2022)
3.1.2 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sustained Release Ocular Drug Delivery Systems in 2021
3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers (2017-2022)
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Sustained Release Ocular Drug Delivery Systems Revenue in 2021
3.3 Global Sustained Release Ocular Drug Delivery Systems Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Sustained Release Ocular Drug Delivery Systems Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Type
4.1.1 Global Sustained Release Ocular Drug Delivery Systems Historical Sales by Type (2017-2022)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Forecasted Sales by Type (2023-2028)
4.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2017-2028)
4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Type
4.2.1 Global Sustained Release Ocular Drug Delivery Systems Historical Revenue by Type (2017-2022)
4.2.2 Global Sustained Release Ocular Drug Delivery Systems Forecasted Revenue by Type (2023-2028)
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2017-2028)
4.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type
4.3.1 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2022)
4.3.2 Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Sustained Release Ocular Drug Delivery Systems Sales by Application
5.1.1 Global Sustained Release Ocular Drug Delivery Systems Historical Sales by Application (2017-2022)
5.1.2 Global Sustained Release Ocular Drug Delivery Systems Forecasted Sales by Application (2023-2028)
5.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2017-2028)
5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Application
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Historical Revenue by Application (2017-2022)
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Forecasted Revenue by Application (2023-2028)
5.2.3 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2017-2028)
5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application
5.3.1 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2022)
5.3.2 Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Application (2023-2028)
6 North America
6.1 North America Sustained Release Ocular Drug Delivery Systems Market Size by Type
6.1.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
6.1.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2028)
6.2 North America Sustained Release Ocular Drug Delivery Systems Market Size by Application
6.2.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
6.2.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2028)
6.3 North America Sustained Release Ocular Drug Delivery Systems Market Size by Country
6.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2028)
6.3.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Type
7.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
7.1.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2028)
7.2 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Application
7.2.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
7.2.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2028)
7.3 Europe Sustained Release Ocular Drug Delivery Systems Market Size by Country
7.3.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2028)
7.3.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Type
8.1.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
8.1.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2028)
8.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Application
8.2.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
8.2.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2028)
8.3 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Size by Region
8.3.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2028)
8.3.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size by Type
9.1.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
9.1.2 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2028)
9.2 Latin America Sustained Release Ocular Drug Delivery Systems Market Size by Application
9.2.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
9.2.2 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2028)
9.3 Latin America Sustained Release Ocular Drug Delivery Systems Market Size by Country
9.3.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2028)
9.3.2 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Type
10.1.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028)
10.1.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2028)
10.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Application
10.2.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028)
10.2.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2028)
10.3 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size by Country
10.3.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2028)
10.3.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 pSivida
11.1.1 pSivida Corporation Information
11.1.2 pSivida Overview
11.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 pSivida Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Icon Bioscience
11.3.1 Icon Bioscience Corporation Information
11.3.2 Icon Bioscience Overview
11.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Icon Bioscience Recent Developments
11.4 Ocular Therapeutix
11.4.1 Ocular Therapeutix Corporation Information
11.4.2 Ocular Therapeutix Overview
11.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ocular Therapeutix Recent Developments
11.5 Neurotech Pharmaceuticals
11.5.1 Neurotech Pharmaceuticals Corporation Information
11.5.2 Neurotech Pharmaceuticals Overview
11.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Neurotech Pharmaceuticals Recent Developments
11.6 Santen Pharmaceutical
11.6.1 Santen Pharmaceutical Corporation Information
11.6.2 Santen Pharmaceutical Overview
11.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Santen Pharmaceutical Recent Developments
11.7 Aciont Inc.
11.7.1 Aciont Inc. Corporation Information
11.7.2 Aciont Inc. Overview
11.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aciont Inc. Recent Developments
11.8 Envisia Therapeutics
11.8.1 Envisia Therapeutics Corporation Information
11.8.2 Envisia Therapeutics Overview
11.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Envisia Therapeutics Recent Developments
11.9 GrayBug
11.9.1 GrayBug Corporation Information
11.9.2 GrayBug Overview
11.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GrayBug Recent Developments
11.10 Innocore Pharmaceuticals
11.10.1 Innocore Pharmaceuticals Corporation Information
11.10.2 Innocore Pharmaceuticals Overview
11.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Innocore Pharmaceuticals Recent Developments
11.11 OHR Pharmaceuticals
11.11.1 OHR Pharmaceuticals Corporation Information
11.11.2 OHR Pharmaceuticals Overview
11.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 OHR Pharmaceuticals Recent Developments
11.12 PolyActiva
11.12.1 PolyActiva Corporation Information
11.12.2 PolyActiva Overview
11.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 PolyActiva Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 PolyActiva Recent Developments
11.13 TheraKine
11.13.1 TheraKine Corporation Information
11.13.2 TheraKine Overview
11.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 TheraKine Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 TheraKine Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sustained Release Ocular Drug Delivery Systems Industry Chain Analysis
12.2 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sustained Release Ocular Drug Delivery Systems Production Mode & Process
12.4 Sustained Release Ocular Drug Delivery Systems Sales and Marketing
12.4.1 Sustained Release Ocular Drug Delivery Systems Sales Channels
12.4.2 Sustained Release Ocular Drug Delivery Systems Distributors
12.5 Sustained Release Ocular Drug Delivery Systems Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
13.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
13.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
13.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
14 Key Findings in The Global Sustained Release Ocular Drug Delivery Systems Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Liposome
Table 3. Major Manufacturers of Microcapsules/Nanocapsules
Table 4. Major Manufacturers of Microspheres/Nanosptheres
Table 5. Major Manufacturers of Implants
Table 6. Global Sustained Release Ocular Drug Delivery Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2017-2022)
Table 10. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2023-2028)
Table 12. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2017-2022)
Table 14. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2023-2028)
Table 16. Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers (2017-2022)
Table 18. Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2017-2022)
Table 20. Sustained Release Ocular Drug Delivery Systems Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2021)
Table 23. Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Offered
Table 25. Date of Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2017-2022)
Table 30. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Type (2023-2028)
Table 31. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2017-2022)
Table 34. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2023-2028)
Table 35. Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2017-2022)
Table 40. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Application (2023-2028)
Table 41. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2017-2022)
Table 44. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2023-2028)
Table 45. Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2023-2028) & (US$ Million)
Table 107. pSivida Corporation Information
Table 108. pSivida Description and Major Businesses
Table 109. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. pSivida Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. pSivida Recent Developments
Table 112. Allergan Corporation Information
Table 113. Allergan Description and Major Businesses
Table 114. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Allergan Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Allergan Recent Developments
Table 117. Icon Bioscience Corporation Information
Table 118. Icon Bioscience Description and Major Businesses
Table 119. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Icon Bioscience Recent Developments
Table 122. Ocular Therapeutix Corporation Information
Table 123. Ocular Therapeutix Description and Major Businesses
Table 124. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Ocular Therapeutix Recent Developments
Table 127. Neurotech Pharmaceuticals Corporation Information
Table 128. Neurotech Pharmaceuticals Description and Major Businesses
Table 129. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Neurotech Pharmaceuticals Recent Developments
Table 132. Santen Pharmaceutical Corporation Information
Table 133. Santen Pharmaceutical Description and Major Businesses
Table 134. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 135. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Santen Pharmaceutical Recent D

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Artificial Tears Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 91

Artificial tears are lubricant eye drops used to treat The dryness and irritation associated with deficient tear production in keratoconjunctivitis sicca (dry eyes). They are also used to moisten contact lenses and in eye examinations. The global Artificial Tears market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 5240.1 million by 2030, witnessing a CAGR of 8.6% during The forecast period 2024-2030. The industry's leading producers are Aller......

Global Contact Lens Solution Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 96

Contact lens solution is a kind of solution that is used to contact lens with The function of cleaning, disinfection, rinsing or preservation, it can also alleviate The eyeball discomfort which caused by wear The contact lens. Contact lens solution can direct contact eyeball, so it must be accord with industrial standard. The global Contact Lens Solution market was valued at US$ 4087.6 million in 2023 and is anticipated to reach US$ 5323.5 million by 2030, witnessing a CAGR of 3.8% ......

Global Latanoprost Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 82

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside The eye. Onset of effects is usually within four hours, and they last for up to a day. Latanoprost is used to treat high pressure inside The eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in The body (prostaglandin) and works by regulating The flow of fluid within The eye which results in lower pressure. Lowerin......

Global Contact Lens Solution Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 99

Market Overview of Global Contact Lens Solution market: According to our latest research, the global Contact Lens Solution market looks promising in the next 5 years. As of 2022, the global Contact Lens Solution market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Contact ......

Global Dry Eye Syndrome Drugs Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 82

The Dry Eye Syndrome Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Syndrome Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive......

Global Eye Drops & Lubricants Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112

According to our LPI (LP Information) latest study, the global Eye Drops & Lubricants market size was valued at US$ 8841.8 million in 2023. With growing demand in downstream market, the Eye Drops & Lubricants is forecast to a readjusted size of US$ 9780.8 million by 2030 with a CAGR of 1.5% during review period. The research report highlights the growth potential of the global Eye Drops & Lubricants market. Eye Drops & Lubricants are expected to show stable growth in the future market. H......

Global Conjunctivitis Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98

According to our LPI (LP Information) latest study, the global Conjunctivitis market size was valued at US$ 3482.7 million in 2023. With growing demand in downstream market, the Conjunctivitis is forecast to a readjusted size of US$ 3908 million by 2030 with a CAGR of 1.7% during review period. The research report highlights the growth potential of the global Conjunctivitis market. Conjunctivitis are expected to show stable growth in the future market. However, product differentiation, r......

Global Contact Lens Solution Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118

According to our LPI (LP Information) latest study, the global Contact Lens Solution market size was valued at US$ 3998.7 million in 2023. With growing demand in downstream market, the Contact Lens Solution is forecast to a readjusted size of US$ 5241.5 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Contact Lens Solution market. Contact Lens Solution are expected to show stable growth in the future market. Howev......

Global Latanoprost Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Latanoprost market size was valued at US$ 1344.2 million in 2023. With growing demand in downstream market, the Latanoprost is forecast to a readjusted size of US$ 1574.2 million by 2030 with a CAGR of 2.3% during review period. The research report highlights the growth potential of the global Latanoprost market. Latanoprost are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs